News Bulletin
Tuesday, February 24 2026
Morning Edition
Economic Numbers:
|
Time |
Event |
Forecast |
Previous |
|
Tuesday,
February 24, 2026 |
|
||
|
8:15 |
|
10.30K |
|
|
8:55 |
|
0.072 |
|
|
9:00 |
|
0.00% |
|
|
9:00 |
1.30% |
1.40% |
|
|
9:00 |
|
|
|
|
9:00 |
|
0.50% |
|
|
9:00 |
|
1.90% |
|
|
9:00 |
|
439.3 |
|
|
9:00 |
0.30% |
0.60% |
|
|
9:00 |
|
|
|
|
9:10 |
|
|
|
|
9:35 |
|
|
|
|
10:00 |
8740.00% |
8450.00% |
|
|
10:00 |
-8 |
-6 |
|
|
10:00 |
|
-300.00% |
|
|
10:00 |
0.20% |
0.20% |
|
|
10:00 |
|
-5 |
|
|
10:00 |
|
1.30% |
|
|
10:30 |
|
780.00% |
|
|
10:30 |
|
2.7 |
|
|
11:30 |
3.10% |
3.10% |
|
|
13:00 |
|
3.58% |
|
|
13:00 |
|
22.40T |
|
|
15:15 |
|
|
|
|
15:20 |
|
|
|
|
16:30 |
|
-0.609M |
|
|
21:00 |
|
|
|
Indices
|
|
CLOSE |
50 DMA |
200 DMA |
|
DJIA |
48,804.06 |
49,024.77 |
46,029.20 |
|
NASDAQ |
22,627.27 |
23,274.97 |
21,903.17 |
|
S&P 500 |
6,837.75 |
6,895.99 |
6,535.79 |
Earnings Calendar:
(EPS: Earning Per Share / Rev: Revenue / Mkt Cap : market Capital/ BMO :
Before Market Opening /AMC : After Market Close)
|
Company |
EPS |
Consensus |
Previous |
Revenue |
Consensus |
Previous |
MarketCap |
Fiscal |
Time |
|
2.54 |
38.14B |
$333.52B |
Q4 |
AM |
|||||
|
38.00% |
1.36B |
$267.21B |
Q4 |
PM |
|||||
|
231.00% |
4.95B |
$91.22B |
Q4 |
AM |
|||||
|
1.49 |
2.68B |
$82.19B |
Q4 |
AM |
|||||
|
228.00% |
2.51B |
$61.89B |
Q4 |
PM |
|||||
|
231.00% |
5.85B |
$59.02B |
Q4 |
PM |
|||||
|
1.6 |
755.55M |
$54.08B |
Q4 |
PM |
|||||
|
59.00% |
4.36B |
$37.22B |
Q4 |
AM |
|||||
|
102.00% |
6.38B |
$36.53B |
Q4 |
AM |
|||||
|
1.69 |
2.75B |
$34.86B |
Q4 |
AM |
|||||
|
110.00% |
2.84B |
$28.9B |
Q4 |
AM |
|||||
|
27.00% |
892.19M |
$27.08B |
Q4 |
PM |
|||||
|
5.18 |
1.58B |
$25.01B |
Q4 |
PM |
|||||
|
78.00% |
13.83B |
$23.82B |
Q1 |
PM |
|||||
|
1.41 |
2.8B |
$19.65B |
Q4 |
AM |
|||||
|
40.00% |
494.84M |
$14.87B |
Q4 |
PM |
|||||
|
158.00% |
1.27B |
$14.55B |
Q4 |
PM |
|||||
|
8.98 |
2.01B |
$9.67B |
Q4 |
AM |
|||||
|
130.00% |
3.34B |
$9.29B |
Q4 |
AM |
|||||
|
80.00% |
3.48B |
$9.02B |
Q4 |
PM |
|||||
|
0.44 |
192.64M |
$8.99B |
Q4 |
AM |
|||||
|
70.00% |
751.88M |
$8.87B |
Q4 |
PM |
|||||
|
-125.00% |
2.64B |
$8.78B |
Q4 |
AM |
|||||
|
1.07 |
777.49M |
$8.35B |
Q4 |
PM |
|||||
|
168.00% |
400.86M |
$8.3B |
Q4 |
AM |
|||||
|
38.00% |
261.3M |
$7.72B |
Q4 |
PM |
|||||
|
-1.56 |
7.12M |
$6.99B |
Q4 |
PM |
|||||
|
46.00% |
529.05M |
$6.29B |
Q4 |
PM |
|||||
|
2.77 |
789.05M |
$5.54B |
Q4 |
PM |
|||||
|
100.00% |
834.22M |
$5.48B |
Q4 |
PM |
|||||
|
61.00% |
528.01M |
$5.31B |
Q4 |
AM |
|||||
|
0.95 |
388.17M |
$4.81B |
Q4 |
PM |
|||||
|
1159.00% |
1.27B |
$4.64B |
Q4 |
AM |
|||||
|
46.00% |
1.46B |
$4.46B |
Q4 |
AM |
|||||
|
0.26 |
143.16M |
$3.67B |
Q4 |
PM |
|||||
|
32.00% |
144.54M |
$3.55B |
Q4 |
PM |
|||||
|
41.00% |
207.1M |
$3.12B |
Q4 |
PM |
|||||
|
1.95 |
435.44M |
$3.02B |
Q4 |
PM |
|||||
|
73.00% |
365.18M |
$2.92B |
Q4 |
PM |
|||||
|
33.00% |
667.15M |
$2.84B |
Q4 |
AM |
|||||
|
-2.54 |
382.49M |
$2.66B |
Q4 |
PM |
|||||
|
220.00% |
149.97M |
$1.78B |
Q2 |
PM |
|||||
|
0.7 |
302.57M |
$1.71B |
Q4 |
AM |
|||||
|
168.00% |
320.38M |
$1.56B |
Q4 |
AM |
|||||
|
-6.00% |
70.94M |
$1.37B |
Q4 |
PM |
|||||
|
0.37 |
328.46M |
$1.15B |
Q4 |
PM |
|||||
|
25.00% |
169M |
$489.9M |
Q4 |
AM |
Market
News:
U.S. stock
index futures rose slightly Tuesday, bouncing
after the previous session’s selloff as investors digested heightened
uncertainty over global trade and AI disruptions fears ahead of key Nvidia earnings. At 05:45 ET (10:45 GMT), Dow Jones Futures
rose 60 points, or 0.1%, S&P 500 Futures gained 13 points, or 0.2%, and Nasdaq 100 Futures advanced 66 points, or 0.3%.
Home Depot
(NYSE:HD) stock rose 2.1% after the home-improvement chain
operator topped estimates for fourth-quarter results and maintained its annual
forecasts, benefiting from resilient demand from budget-strapped customers.
Novo
Nordisk (CSE:NOVOb) stock dropped
2.9% after JPMorgan downgraded the drugmaking giant
to ‘neutral’ from ‘overweight’ after disappointing late-stage results for its
obesity drug CagriSema showed weaker-than-expected
competitiveness versus Eli Lilly’s Zepbound.
Keurig Dr Pepper (NASDAQ:KDP) stock rose
2.1% after the soft drinks company reported fourth-quarter results that
exceeded expectations, while its revenue guidance for fiscal 2026 also
impressed, driven by the anticipated acquisition of JDE Peet’s.
DigitalOcean (NYSE:DOCN) stock slipped
1.4% despite the cloud infrastructure provider reporting fourth quarter results
that exceeded expectations and raised its revenue outlook for 2026 and 2027.
The stock is up over 23% year to date.
Advanced
Micro Devices (NASDAQ:AMD) stock surged 10% after the company
agreed to sell up to $60 billion worth of artificial intelligence chips to Meta
Platforms over five years in a deal that allows the Facebook
owner to purchase as much as 10% of the chip firm.
Planet
Fitness (NYSE:PLNT) stock fell 4.9% after the operator of
fitness centers reported a disappointing 2026
outlook, even as fourth-quarter results topped expectations.
Keysight Technologies (NYSE:KEYS) stock soared
13% after the electronic equipment maker forecast second-quarter profit ahead
of Wall Street estimates.
Hims Hers Health (NYSE:HIMS) stock slipped
4.3% after the online telehealth company forecast
first-quarter revenue below estimates.
or internal use only